- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Rituximab – July 2017
Rituximab: Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL, Solution for I.V. infusion 100 mg in 10 mL, Solution for I.V. infusion 500 mg in 50 mL; MabThera® SC, MabThera®
Last updated
27 October 2017